Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (131-140 of 904) with videos related to

Pageof 91
Sort By:
Haematologica|July 20, 2004
FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophiliaAyalew Tefferi, Terra L Lasho, Stephanie R Brockman, et al.
British Journal of Haematology|December 17, 2008
Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid diseaseBatia Kaplan, Marina Ramirez-Alvarado, Laura Sikkink, et al.
Mayo Clinic Proceedings|July 4, 2007
Endocrinopathy in POEMS syndrome: the Mayo Clinic experienceGunjan Y Gandhi, Rita Basu, Angela Dispenzieri, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 13, 2021
Development of a conceptual model of patient-reported outcomes in light chain amyloidosis: a qualitative studyAnita D'Souza, Judith Myers, Rachel Cusatis, et al.
Future Cardiology|November 26, 2025
A real-world study of tafamidis in people with transthyretin amyloid cardiomyopathy (ATTR-CM) with heart and nerve symptoms: a plain language summaryJonas Wixner, Angela Dispenzieri, Leslie Amass, et al.
Blood|January 21, 2006
Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myelomaApollina Goel, Angela Dispenzieri, Susan M Geyer, et al.
American Journal of Hematology|October 16, 2024
Cryoablation for unresectable unicentric Castleman diseaseYoshito Nishimura, Thomas Atwell, Matthew Callstrom, et al.
Kidney International|February 5, 2010
Recurrent membranoproliferative glomerulonephritis after kidney transplantationElizabeth C Lorenz, Sanjeev Sethi, Nelson Leung, et al.
Leukemia|March 24, 2018
The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete responseSurbhi Sidana, Nidhi Tandon, Angela Dispenzieri, et al.
Clinical Chemistry and Laboratory Medicine|August 4, 2020
Automation and validation of a MALDI-TOF MS (Mass-Fix) replacement of immunofixation electrophoresis in the clinical labMindy Kohlhagen, Surendra Dasari, Maria Willrich, et al.
Pageof 91

Showing results (131-140 of 904) with videos related to

Sort By:
Pageof 91
Haematologica|July 20, 2004
FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophiliaAyalew Tefferi, Terra L Lasho, Stephanie R Brockman, et al.
British Journal of Haematology|December 17, 2008
Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid diseaseBatia Kaplan, Marina Ramirez-Alvarado, Laura Sikkink, et al.
Mayo Clinic Proceedings|July 4, 2007
Endocrinopathy in POEMS syndrome: the Mayo Clinic experienceGunjan Y Gandhi, Rita Basu, Angela Dispenzieri, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 13, 2021
Development of a conceptual model of patient-reported outcomes in light chain amyloidosis: a qualitative studyAnita D'Souza, Judith Myers, Rachel Cusatis, et al.
Future Cardiology|November 26, 2025
A real-world study of tafamidis in people with transthyretin amyloid cardiomyopathy (ATTR-CM) with heart and nerve symptoms: a plain language summaryJonas Wixner, Angela Dispenzieri, Leslie Amass, et al.
Blood|January 21, 2006
Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myelomaApollina Goel, Angela Dispenzieri, Susan M Geyer, et al.
American Journal of Hematology|October 16, 2024
Cryoablation for unresectable unicentric Castleman diseaseYoshito Nishimura, Thomas Atwell, Matthew Callstrom, et al.
Kidney International|February 5, 2010
Recurrent membranoproliferative glomerulonephritis after kidney transplantationElizabeth C Lorenz, Sanjeev Sethi, Nelson Leung, et al.
Leukemia|March 24, 2018
The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete responseSurbhi Sidana, Nidhi Tandon, Angela Dispenzieri, et al.
Clinical Chemistry and Laboratory Medicine|August 4, 2020
Automation and validation of a MALDI-TOF MS (Mass-Fix) replacement of immunofixation electrophoresis in the clinical labMindy Kohlhagen, Surendra Dasari, Maria Willrich, et al.
Pageof 91